Chiesi USA, Inc. Sustainability Profile
Chiesi USA, Inc., a subsidiary of the Chiesi Group, is a prominent player in the pharmaceutical industry, headquartered in the United States. Established in 1935, the company has made significant strides in developing innovative therapies, particularly in the fields of respiratory, neonatology, and rare diseases. With a strong presence across major operational regions in North America, Chiesi USA is dedicated to improving patient outcomes through its unique portfolio of products. The company is renowned for its commitment to sustainability and patient-centric solutions, offering a range of inhalation therapies and specialty pharmaceuticals that stand out for their efficacy and safety. Chiesi USA has garnered recognition for its contributions to healthcare, positioning itself as a leader in the biopharmaceutical sector, while continuously striving for excellence in research and development.
DitchCarbon Score
How does Chiesi USA, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Chiesi USA, Inc.'s score of 76 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Chiesi USA, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Chiesi Farmaceutici S.p.A., which provides emissions data and climate commitments at a higher corporate level. Chiesi Farmaceutici S.p.A. has set ambitious climate commitments, including science-based targets for emissions reductions. However, specific reduction targets or achievements for Chiesi USA, Inc. have not been detailed in the available information. The company is part of a broader initiative to enhance sustainability and reduce carbon footprints across its operations, inheriting commitments and performance metrics from its parent organisation. As a current subsidiary, Chiesi USA, Inc. aligns with the sustainability goals established by Chiesi Farmaceutici S.p.A., which include participation in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). These initiatives aim to drive significant reductions in greenhouse gas emissions across all scopes, although specific figures for Scope 1, 2, or 3 emissions for Chiesi USA, Inc. have not been disclosed. In summary, while Chiesi USA, Inc. does not present specific emissions data or reduction targets, it is committed to the overarching climate strategies of its parent company, Chiesi Farmaceutici S.p.A., focusing on sustainability and emissions reduction in the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 18,840,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 16,872,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 000,000 | 000,000 | 000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Chiesi USA, Inc.'s Industry?
How Carbon Intensive is Chiesi USA, Inc.'s Location?
Chiesi USA, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Chiesi USA, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
